| Serial Number | 86836612 |
| Word Mark | SL SNOTRA LABORATORIES |
| Filing Date | Wednesday, December 2, 2015 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 29, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 1, 2016 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "LABORATORIES" |
| Description of Mark | The mark consists of a stylized "S" and a stylized "L" forming a robotic arm grip to the left of the words SNOTRA LABORATORIES and a diacritical mark over the "o" in SNOTRA. |
| Goods and Services | Project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; providing project management services for others for business purposes related to the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business consultation in the field of healthcare, namely, providing independent consultative review of clinical trials, peri-approval studies, post-approval studies, observational studies, post-approval surveys and clinical patient registries, post-approval marketing studies, quality improvement, and patient support programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries all excluding the provision of medical services and medical treatment services |
| Goods and Services | Scientific research and development; conducting research and development services in the field of pharmaceuticals and medical devices; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; conducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others; medical and scientific research in the nature of conducting peri-approval studies and post-approval studies evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies an medical services; providing information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; medical and scientific research featuring peri-approval studies and post-approval studies for evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies, and medical services |
| Goods and Services | Medical services in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices. Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 8, 2015 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 22, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 8, 2015 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SNOTRA LABORATORIES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Saugus, MA 01906 |
| Party Name | SNOTRA LABORATORIES, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Saugus, MA 01906 |
| Event Date | Event Description |
| Monday, January 29, 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, January 29, 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, June 24, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 22, 2017 | EXTENSION 1 GRANTED |
| Thursday, June 22, 2017 | EXTENSION 1 FILED |
| Thursday, June 22, 2017 | TEAS EXTENSION RECEIVED |
| Tuesday, December 27, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 1, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 1, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 12, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 23, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 22, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 22, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 22, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, March 24, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, March 24, 2016 | NON-FINAL ACTION E-MAILED |
| Thursday, March 24, 2016 | NON-FINAL ACTION WRITTEN |
| Monday, March 21, 2016 | ASSIGNED TO EXAMINER |
| Wednesday, December 9, 2015 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, December 8, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, December 5, 2015 | NEW APPLICATION ENTERED IN TRAM |